Bank of Nova Scotia’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Bank of Nova Scotia's AGL Position: Q4 2024 in Review
Bank of Nova Scotia sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 3,026 shares — an estimated $297K sold.
Bank of Nova Scotia first reported a position in AGL in Q4 2023 and held it in 4 quarters. The position peaked at $333K in Q2 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.
- Bank of Nova Scotia reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
- Bank of Nova Scotia sold 3,026 Agilon Health shares in Q4 2024, an estimated $297K.
- Bank of Nova Scotia first reported a position in Agilon Health in Q4 2023 and held it in 4 quarters.
- Bank of Nova Scotia's Agilon Health position peaked at $333K in Q2 2024.
- 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.
Based on Bank of Nova Scotia's 13F filing for Q4 2024, filed 13 Feb 2025.